|
[1] Wu JH, Cui Y, Zhang XY, Gui L, Wang YN, Peng SQ*, Zhao M*. BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral beta-carboline-3-carboxylic acid [J]. Int J Nanomedicine, 2019, 14, 3027-3041.IF="5.115
[2] Wu JN, Zhu HM, Yang GD, He J, Wang YN, Zhao SR, Zhang XY, Gui L, Zhao M*, Peng SQ*. Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA [J]. Int J Nanomedicine, 2018, 13, 1139-1158. IF="5.115
[3] Wu JH#, Zhu HM#, Zhao M*, Wang YJ, Yang GD, Wang YN, Zhao SR, Gui L, Zhang XY, Peng SQ*. IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo [J]. J Mater Chem B, 2017, 5(5): 877–1120. IF=5.003
[4] Wu JH, Zhao M*, Wang YJ, Wang YN, Zhu HM, Zhao SR, Gui L, Zhang XY, PengSQ*.N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation [J]. Drug Des Devel Ther, 2017, 11, 225-239. IF="3.254
[5]Wu JH, Zhao M*, Wang YJ, Wang YN, Zhu HM, Zhao SR, and Peng SQ*, A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism.Bioorganic & Medicinal Chemistry Letter, 2016, 26, 4631- 4636. IF="2.352"
|
